BVNRY:OTCMKTS
Bavarian Nordic A/S - ADR
$11.10
arrow_upward
+0.14%(+0.015) 1D
Oct 6, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BVNRY...
Open
$11.37
High
$11.37
Low
$11.10
Mkt. cap
2.59B
Avg. vol.
2.64K
Volume
753.00
P/E ratio
11.89
52-wk high
$13.00
52-wk low
$8.67
EPS
$0.93
Beta
1.45
Shares outstanding
237.82M
No. of employees
2K
Open
$11.37
High
$11.37
Low
$11.10
Mkt. cap
2.59B
Avg. vol.
2.64K
Volume
753.00
P/E ratio
11.89
52-wk high
$13.00
52-wk low
$8.67
EPS
$0.93
Beta
1.45
Shares outstanding
237.82M
No. of employees
2K
News stories
From web sources and news partners
DailyForex
·
7 minutes ago
Forex Today 07/10: S&P 500 and Nasdaq Close at Record Highs
The Motley Fool
·
1 hour ago
Microsoft Stock Is on Track to Trail the S&P 500 for a 3rd Straight Year. History Says What Happened After Its Last 2 Streaks.
Benzinga
·
34 minutes ago
Which 10 Stocks Command 41 Cents of Every S&P 500 Dollar? - State Street SPDR S&P 500 ETF Trust (ARCA:SPY
TradingView
·
1 hour ago
Stock Market: Will S&P 500 Open Up or Down Today?
Profile
Bavarian Nordic A/S is a Danish biotechnology company focused on the development, manufacturing and commercialization of vaccines. The company is headquartered in Hellerup, Denmark, with manufacturing facilities in Kvistgård, Denmark and Thörishaus near Bern, Switzerland. The company has research and development facilities in Martinsried, Germany, as well as offices in USA, Canada, and France. The company uses viral vectors and virus-like particles in its research and development.
In July 2025, the company agreed to be acquired by private equity firms Permira and Nordic Capital for 19 billion kr. However, in November, the acquisition failed to gain sufficient support from Bavarian Nordic's shareholders, leading to its termination.
In 2026, Bavarian Nordic was ranked second in Time Magazine's World Most Impactful Companies. Wikipedia
About Bavarian Nordic A/S - ADR
CEOPaul Chaplin
Employees1.91K
FoundedJul 1, 1992
Headquarters-
SectorBiotechnology
Websitebavarian-nordic.com